Close Menu

Ohio State

Two independent research groups this week reported in The Journal of Clinical Investigation on the role of microRNA-122 in the liver, showing that the non-coding RNA is critical for fat and cholesterol metabolism in the organ and that it may play an important role in tum

Building on studies examining the roles of microRNAs in cancer cell-derived circulating microvesicles, a team of researcher from Ohio State University this month reported on the discovery that two such miRNAs trigger a pro-metastatic inflammatory response by binding to toll-like

Gen-Probe has been awarded US Patent No. 8,192,992, "System and method for incubating the contents of a reaction receptacle."
Kelly Ammann, Robert Schneider, and Robert Smith are named as inventors on the patent.

OSU's new P4 Scholars program educates medical students in predictive, preventive, personalized, and participatory medicine.

A study published earlier this spring by OSU researchers identified a set of miRNA signatures in blood that could yield a new test for lung cancer development and prognosis.

Researchers at OSU used the 75-teraflop supercomputer to perform sequence alignments and statistical analysis as well as to generate phylogenetic trees to shed light on the evolutionary history of the PARP protein family.

The aim of the effort is to assess the utility of incorporating genomic testing data in patients' electronic medical records.


The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.